Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RESILIÉLLE
- Development stage
- Unknown
- Lead developer
- RESILIÉLLE Cosmetics
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
RESILIÉLLE is a topical cosmeceutical product composed of exosomes derived from human mesenchymal stem cells (hMSCs), specifically Wharton's Jelly mesenchymal stromal cells from donated umbilical cords. Developed by RESILIÉLLE Cosmetics LLC, a subsidiary of The Crowley Center for Regenerative & Biotherapeutics and launched by AT Venture Center, the product utilizes 'Age Zero Exosomes' technology. It is primarily indicated for skin rejuvenation and as a post-procedure treatment following microneedling, laser therapy, or other skin abrasion treatments to accelerate recovery, reduce redness, and improve hyperpigmentation. The exosomes function as mediators of cell-to-cell communication, delivering functional proteins and bioactive molecules to the skin to promote repair and regenerative processes.
- Brand names
- RESILIÉLLE
- Other names
- Age Zero Exosomes
Beyond the preview
Go deeper on RESILIÉLLE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RESILIÉLLE.